Dexamethasone or other corticosteroid

PreclinicalSmall molecule

Dexamethasone or other corticosteroid is one of 26 small molecule programs targeting Dexamethasone. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DexamethasoneCompleted

DexamethasonePreclinical

Completed

Competition

Competitive Landscape

31 competitors in Dexamethasone

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Rayos

3 3

Revlimid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

16 4

Empliciti

Bristol-Myers Squibb

Phase 3

1 5

Velcade

SShilpa Grover, MD, MPH

Phase 3

8 6

Kyprolis

VVirionyx Corporation Limited

Phase 3

5 7

Zyprexa

MMODAG GmbH

Phase 3

3 8

Decadron

QQuince Therapeutics S.p.A.

Phase 3

2 9

Ninlaro

Takeda

Phase 2

3 10

Belamaf

GSK

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Dexamethasone1 trial

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

Completed·NNYU Langone Health·N/A·NCT00007358·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dexamethasone or other corticosteroid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexamethasone or other corticosteroid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexamethasone or other corticosteroid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — NYU Langone Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNYU Langone Health

Dexamethasone or other corticosteroid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Dexamethasone1 trial

References

Drug Info

Quick Facts

Related News